Vito Sansone

485 total citations
22 papers, 261 citations indexed

About

Vito Sansone is a scholar working on Hepatology, Epidemiology and Surgery. According to data from OpenAlex, Vito Sansone has authored 22 papers receiving a total of 261 indexed citations (citations by other indexed papers that have themselves been cited), including 11 papers in Hepatology, 7 papers in Epidemiology and 5 papers in Surgery. Recurrent topics in Vito Sansone's work include Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cancer Mechanisms and Therapy (3 papers). Vito Sansone is often cited by papers focused on Hepatocellular Carcinoma Treatment and Prognosis (11 papers), Liver Disease Diagnosis and Treatment (5 papers) and Cancer Mechanisms and Therapy (3 papers). Vito Sansone collaborates with scholars based in Italy, United States and Switzerland. Vito Sansone's co-authors include Francesco Tovoli, Luca Ielasi, Fabio Piscaglia, Alessandro Granito, Matteo Renzulli, A. Forgione, Francesca Benevento, Sara Marinelli, Hans P. Drobeck and Rita Golfieri and has published in prestigious journals such as Blood, Journal of Hepatology and Nutrients.

In The Last Decade

Vito Sansone

21 papers receiving 250 citations

Peers — A (Enhanced Table)

Peers by citation overlap · career bar shows stage (early→late) cites · hero ref

Name h Career Trend Papers Cites
Vito Sansone Italy 9 122 73 68 57 51 22 261
Chun‐Hui Nie China 11 162 1.3× 100 1.4× 61 0.9× 68 1.2× 63 1.2× 31 333
Le-Qun Li China 8 193 1.6× 66 0.9× 35 0.5× 88 1.5× 37 0.7× 13 305
Yoon Jin Hwang South Korea 8 167 1.4× 111 1.5× 49 0.7× 74 1.3× 51 1.0× 18 399
Naomi Funaki Japan 12 133 1.1× 120 1.6× 84 1.2× 114 2.0× 32 0.6× 25 389
Masaki Tateishi Japan 12 173 1.4× 94 1.3× 155 2.3× 88 1.5× 117 2.3× 31 416
Jiashuo Chao China 9 67 0.5× 60 0.8× 116 1.7× 32 0.6× 45 0.9× 20 255
Zhao Yin-nong China 10 85 0.7× 99 1.4× 114 1.7× 77 1.4× 42 0.8× 24 406
Xihui Ying China 9 188 1.5× 58 0.8× 102 1.5× 53 0.9× 95 1.9× 18 397
Feng Shen China 7 357 2.9× 125 1.7× 75 1.1× 145 2.5× 63 1.2× 13 477

Countries citing papers authored by Vito Sansone

Since Specialization
Citations

This map shows the geographic impact of Vito Sansone's research. It shows the number of citations coming from papers published by authors working in each country. You can also color the map by specialization and compare the number of citations received by Vito Sansone with the expected number of citations based on a country's size and research output (numbers larger than one mean the country cites Vito Sansone more than expected).

Fields of papers citing papers by Vito Sansone

Since Specialization
Physical SciencesHealth SciencesLife SciencesSocial Sciences

This network shows the impact of papers produced by Vito Sansone. Nodes represent research fields, and links connect fields that are likely to share authors. Colored nodes show fields that tend to cite the papers produced by Vito Sansone. The network helps show where Vito Sansone may publish in the future.

Co-authorship network of co-authors of Vito Sansone

This figure shows the co-authorship network connecting the top 25 collaborators of Vito Sansone. A scholar is included among the top collaborators of Vito Sansone based on the total number of citations received by their joint publications. Widths of edges represent the number of papers authors have co-authored together. Node borders signify the number of papers an author published with Vito Sansone. Vito Sansone is excluded from the visualization to improve readability, since they are connected to all nodes in the network.

All Works

20 of 20 papers shown
1.
Sansone, Vito, Giuseppe Auteri, Francesco Tovoli, et al.. (2024). Liver and spleen shear-wave elastography in the diagnosis and severity staging of myeloproliferative diseases and myelofibrosis. Journal of Ultrasound. 27(3). 715–722. 1 indexed citations
2.
Ignee, A, Kathleen Möller, Ehsan Safai Zadeh, et al.. (2023). Comments and illustrations of the WFUMB CEUS liver guidelines: Rare focal liver lesions – infectious (bacterial). Medical Ultrasonography. 25(3). 312–312. 12 indexed citations
3.
Tovoli, Francesco, et al.. (2022). Risk of Drop-Out from Follow-Up Evaluations for Celiac Disease: Is It Similar for All Patients?. Nutrients. 14(6). 1223–1223. 1 indexed citations
4.
Tovoli, Francesco, Vito Sansone, Massimo Iavarone, et al.. (2022). Outcomes of Sorafenib for Recurrent Hepatocellular Carcinoma After Liver Transplantation in the Era of Combined and Sequential Treatments. Transplantation. 107(1). 156–161. 8 indexed citations
5.
Ielasi, Luca, Francesco Tovoli, Raffaella Tortora, et al.. (2021). Beneficial Prognostic Effects of Aspirin in Patients Receiving Sorafenib for Hepatocellular Carcinoma: A Tale of Multiple Confounders. Cancers. 13(24). 6376–6376. 14 indexed citations
6.
Granito, Alessandro, A. Forgione, Sara Marinelli, et al.. (2021). Experience with regorafenib in the treatment of hepatocellular carcinoma. Therapeutic Advances in Gastroenterology. 14. 1088199935–1088199935. 100 indexed citations
7.
Sansone, Vito, Francesco Tovoli, Andrea Casadei‐Gardini, et al.. (2021). Comparison of Prognostic Scores in Patients With Hepatocellular Carcinoma Treated With Sorafenib. Clinical and Translational Gastroenterology. 12(1). e00286–e00286. 12 indexed citations
8.
Auteri, Giuseppe, Vito Sansone, Daniela Bartoletti, et al.. (2021). Spleen and Liver Fibrosis Is Associated to Treatment Response and Prognosis in Philadelphia-Negative Chronic Myeloproliferative Neoplasms. Blood. 138(Supplement 1). 3626–3626. 2 indexed citations
9.
Ielasi, Luca, et al.. (2021). An update on atezolizumab for hepatocellular carcinoma. Drugs of today. 57(6). 365–365. 1 indexed citations
10.
Rimini, Margherita, Sara Lonardi, Gianluca Masi, et al.. (2021). Role of the prognostic nutritional index in predicting survival in advanced hepatocellular carcinoma treated with regorafenib. Hepatology Research. 51(7). 796–802. 5 indexed citations
11.
Sansone, Vito, Marco Le Grazie, Simone Polvani, et al.. (2020). Telomerase reactivation is associated with hepatobiliary and pancreatic cancers. Hepatobiliary & pancreatic diseases international. 19(5). 420–428. 7 indexed citations
12.
Sansone, Vito, Lorenzo Falsetti, Francesco Tovoli, et al.. (2020). An Uncommon Focal Liver Lesion: Intrahepatic Splenosis. Journal of Gastrointestinal and Liver Diseases. 29(2). 257–262. 4 indexed citations
13.
Leoni, Simona, Vito Sansone, Stefania De Lorenzo, et al.. (2020). Treatment of Combined Hepatocellular and Cholangiocarcinoma. Cancers. 12(4). 794–794. 36 indexed citations
14.
15.
Tovoli, Francesco, Giulia Negrini, Vito Sansone, et al.. (2018). Celiac Disease Diagnosed through Screening Programs in At-Risk Adults Is Not Associated with Worse Adherence to the Gluten-Free Diet and Might Protect from Osteopenia/Osteoporosis. Nutrients. 10(12). 1940–1940. 10 indexed citations
16.
Ielasi, Luca, Vito Sansone, Alessandro Granito, et al.. (2018). An update of treatments of hepatocellular carcinoma in patientsrefractory to sorafenib. Drugs of today. 54(10). 615–615. 7 indexed citations
17.
Piscaglia, Fabio, Annalisa Berzigotti, Ivan Amat‐Roldan, et al.. (2018). Non-invasive measurement of HVPG using graph analysis based on dynamic contrast-enhanced ultrasound with ESAOTE MyLab: The CLEVER Study. Digestive and Liver Disease. 50(1). 33–33. 1 indexed citations
18.
Berzigotti, Annalisa, Fabio Piscaglia, Ivan Amat‐Roldan, et al.. (2018). Non-invasive measurement of HVPG using graph analysis of dynamic contrast-enhanced ultrasound: the CLEVER study. Journal of Hepatology. 68. S76–S77. 4 indexed citations
19.
Bonetti, Matteo, et al.. (2007). [Early infantile and late infantile form of Krabbe disease: CT and MRI findings].. PubMed. 29(4). 206–11. 1 indexed citations
20.
Drobeck, Hans P., et al.. (1968). Interaction of aspirin with nonsteroidal anti-inflammatory drugs in rats. Journal of Pharmacy and Pharmacology. 20(7). 567–569. 26 indexed citations

Rankless uses publication and citation data sourced from OpenAlex, an open and comprehensive bibliographic database. While OpenAlex provides broad and valuable coverage of the global research landscape, it—like all bibliographic datasets—has inherent limitations. These include incomplete records, variations in author disambiguation, differences in journal indexing, and delays in data updates. As a result, some metrics and network relationships displayed in Rankless may not fully capture the entirety of a scholar's output or impact.

Explore authors with similar magnitude of impact

Breakdown of academic impact, for papers by Chun‐Hui Nie Breakdown of academic impact, for papers by Le-Qun Li Breakdown of academic impact, for papers by Yoon Jin Hwang Breakdown of academic impact, for papers by Naomi Funaki Breakdown of academic impact, for papers by Masaki Tateishi Breakdown of academic impact, for papers by Jiashuo Chao Breakdown of academic impact, for papers by Zhao Yin-nong Breakdown of academic impact, for papers by Xihui Ying Breakdown of academic impact, for papers by Feng Shen
Rankless by CCL
2026